Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment.

Platelets - 1 Jan 2013

Reményi Gyula, Szász Róbert, Debreceni Ildikó Beke, Szarvas Mariann, Batár Péter, Nagy Béla, Kappelmayer János, Udvardy Miklós

Abstract excerpt

Essential thrombocythemia (ET) is an acquired myeloproliferative disorder with sustained increase of platelet count. This disease may be associated with thrombotic or bleeding complications due to the altered number and function of platelets. Coated-platelets produced by a simultaneous activation of collagen and thrombin represent a subpopulation of activated platelets with high prothombinase activity and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Blood Platelets

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Hydroxyurea

Share to Janus Kinase 2

Share to Platelet Activation

Share to Platelet Function Tests

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 23216455
DOI: 10.3109/09537104.2012.731112

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment.PMID 23216455Read ↗

Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.Semantic proximity Read ↗

Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera.Semantic proximity Read ↗

The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.Semantic proximity Read ↗

Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis.Semantic proximity Read ↗

Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia.Semantic proximity Read ↗

[Vascular complications of essential thrombocythemia].Semantic proximity Read ↗

Phosphatidylserine-exposing blood and endothelial cells contribute to the hypercoagulable state in essential thrombocythemia patients.Semantic proximity Read ↗

V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules.Semantic proximity Read ↗

[Summary of pathophysiology and diagnosis of patients with platelet abnormality].Semantic proximity Read ↗

JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia.Semantic proximity Read ↗

Platelet Function and Microvesicles Generation in Patients with Hemophilia ASemantic proximity Read ↗

Extrinsic blood coagulation pathway and risk factors for thrombotic events in patients with essential thrombocythemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.